| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |